S.R. Schill & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-904
| Closed | -$801K | – | 29 |
|
|
2024
Q3 | $801K | Hold |
904
| – | – | 0.57% | 18 |
|
|
2024
Q2 | $818K | Hold |
904
| – | – | 0.36% | 30 |
|
|
2024
Q1 | $703K | Buy |
904
+5
| +0.6% | +$3.56K | 0.31% | 37 |
|
|
2023
Q4 | $524K | Hold |
899
| – | – | 0.23% | 43 |
|
|
2023
Q3 | $483K | Hold |
899
| – | – | 0.23% | 43 |
|
|
2023
Q2 | $422K | Hold |
899
| – | – | 0.19% | 48 |
|
|
2023
Q1 | $309K | Hold |
899
| – | – | 0.14% | 56 |
|
|
2022
Q4 | $329K | Hold |
899
| – | – | 0.16% | 51 |
|
|
2022
Q3 | $291K | Sell |
899
-155
| -15% | -$49.1K | 0.16% | 51 |
|
|
2022
Q2 | $342K | Hold |
1,054
| – | – | 0.17% | 43 |
|
|
2022
Q1 | $302K | Sell |
1,054
-2,883
| -73% | -$742K | 0.13% | 61 |
|
|
2021
Q4 | $1.09M | Sell |
3,937
-400
| -9% | -$101K | 0.43% | 25 |
|
|
2021
Q3 | $1M | Sell |
4,337
-600
| -12% | -$148K | 0.43% | 27 |
|
|
2021
Q2 | $1.13M | Hold |
4,937
| – | – | 0.45% | 29 |
|
|
2021
Q1 | $922K | Hold |
4,937
| – | – | 0.41% | 34 |
|
|
2020
Q4 | $834K | Hold |
4,937
| – | – | 0.38% | 33 |
|
|
2020
Q3 | $731K | Hold |
4,937
| – | – | 0.37% | 33 |
|
|
2020
Q2 | $811K | Hold |
4,937
| – | – | 0.47% | 29 |
|
|
2020
Q1 | $685K | Hold |
4,937
| – | – | 0.46% | 28 |
|
|
2019
Q4 | $649K | Hold |
4,937
| – | – | 0.35% | 45 |
|
|
2019
Q3 | $552K | Hold |
4,937
| – | – | 0.31% | 49 |
|
|
2019
Q2 | $547K | Hold |
4,937
| – | – | 0.34% | 49 |
|
|
2019
Q1 | $641K | Hold |
4,937
| – | – | 0.39% | 45 |
|
|
2018
Q4 | $571K | Hold |
4,937
| – | – | 0.4% | 43 |
|
|
2018
Q3 | $530K | Hold |
4,937
| – | – | 0.33% | 51 |
|
|
2018
Q2 | $421K | Hold |
4,937
| – | – | 0.26% | 61 |
|
|
2018
Q1 | $382K | Hold |
4,937
| – | – | 0.24% | 60 |
|
|
2017
Q4 | $417K | Hold |
4,937
| – | – | 0.26% | 52 |
|
|
2017
Q3 | $422K | Hold |
4,937
| – | – | 0.25% | 50 |
|
|
2017
Q2 | $406K | Hold |
4,937
| – | – | 0.26% | 54 |
|
|
2017
Q1 | $415K | Hold |
4,937
| – | – | 0.26% | 51 |
|
|
2016
Q4 | $363K | Hold |
4,937
| – | – | 0.24% | 54 |
|
|
2016
Q3 | $396K | Hold |
4,937
| – | – | 0.26% | 54 |
|
|
2016
Q2 | $389K | Hold |
4,937
| – | – | 0.26% | 48 |
|
|
2016
Q1 | $356K | Hold |
4,937
| – | – | 0.24% | 51 |
|
|
2015
Q4 | $416K | Hold |
4,937
| – | – | 0.29% | 48 |
|
|
2015
Q3 | $413K | Hold |
4,937
| – | – | 0.29% | 47 |
|
|
2015
Q2 | $412K | Hold |
4,937
| – | – | 0.28% | 52 |
|
|
2015
Q1 | $359K | Sell |
4,937
-498
| -9% | -$35.5K | 0.24% | 50 |
|
|
2014
Q4 | $375K | Buy |
+5,435
| New | +$367K | 0.34% | 41 |
|
Other funds holding LLY
S.R. Schill & Associates's LLY Position: Q4 2024 in Review
S.R. Schill & Associates sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 904 shares — an estimated $801K sold.
S.R. Schill & Associates first reported a position in LLY in Q4 2014 and held it in 40 quarters. The position peaked at $1.13M in Q2 2021. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- S.R. Schill & Associates reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
- S.R. Schill & Associates sold 904 Eli Lilly shares in Q4 2024, an estimated $801K.
- S.R. Schill & Associates first reported a position in Eli Lilly in Q4 2014 and held it in 40 quarters.
- S.R. Schill & Associates's Eli Lilly position peaked at $1.13M in Q2 2021.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on S.R. Schill & Associates's 13F filing for Q4 2024, filed 22 Jan 2025.